147 related articles for article (PubMed ID: 19252313)
1. Contribution of each amino acid residue in polymyxin B(3) to antimicrobial and lipopolysaccharide binding activity.
Kanazawa K; Sato Y; Ohki K; Okimura K; Uchida Y; Shindo M; Sakura N
Chem Pharm Bull (Tokyo); 2009 Mar; 57(3):240-4. PubMed ID: 19252313
[TBL] [Abstract][Full Text] [Related]
2. Development of des-fatty acyl-polymyxin B decapeptide analogs with Pseudomonas aeruginosa-specific antimicrobial activity.
Katsuma N; Sato Y; Ohki K; Okimura K; Ohnishi K; Sakura N
Chem Pharm Bull (Tokyo); 2009 Apr; 57(4):332-6. PubMed ID: 19336926
[TBL] [Abstract][Full Text] [Related]
3. Semi-synthesis of polymyxin B (2-10) and colistin (2-10) analogs employing the Trichloroethoxycarbonyl (Troc) group for side chain protection of alpha,gamma-diaminobutyric acid residues.
Okimura K; Ohki K; Sato Y; Ohnishi K; Sakura N
Chem Pharm Bull (Tokyo); 2007 Dec; 55(12):1724-30. PubMed ID: 18057747
[TBL] [Abstract][Full Text] [Related]
4. Novel des-fatty acyl-polymyxin B derivatives with Pseudomonas aeruginosa-specific antimicrobial activity.
Sato Y; Shindo M; Sakura N; Uchida Y; Kato I
Chem Pharm Bull (Tokyo); 2011; 59(5):597-602. PubMed ID: 21532197
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the hydrophobic domain of polymyxin B nonapeptide: effect on outer-membrane permeabilization and lipopolysaccharide neutralization.
Tsubery H; Ofek I; Cohen S; Eisenstein M; Fridkin M
Mol Pharmacol; 2002 Nov; 62(5):1036-42. PubMed ID: 12391265
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of bacterial outer-membrane permeabilizers based on polymyxin B heptapeptides.
Urakawa H; Yamada K; Komagoe K; Ando S; Oku H; Katsu T; Matsuo I
Bioorg Med Chem Lett; 2010 Mar; 20(5):1771-5. PubMed ID: 20138759
[TBL] [Abstract][Full Text] [Related]
7. The functional association of polymyxin B with bacterial lipopolysaccharide is stereospecific: studies on polymyxin B nonapeptide.
Tsubery H; Ofek I; Cohen S; Fridkin M
Biochemistry; 2000 Oct; 39(39):11837-44. PubMed ID: 11009595
[TBL] [Abstract][Full Text] [Related]
8. Neopeptide antibiotics that function as opsonins and membrane-permeabilizing agents for gram-negative bacteria.
Tsubery H; Yaakov H; Cohen S; Giterman T; Matityahou A; Fridkin M; Ofek I
Antimicrob Agents Chemother; 2005 Aug; 49(8):3122-8. PubMed ID: 16048913
[TBL] [Abstract][Full Text] [Related]
9. N-terminal modifications of Polymyxin B nonapeptide and their effect on antibacterial activity.
Tsubery H; Ofek I; Cohen S; Fridkin M
Peptides; 2001 Oct; 22(10):1675-81. PubMed ID: 11587796
[TBL] [Abstract][Full Text] [Related]
10. Structure-function studies of polymyxin B nonapeptide: implications to sensitization of gram-negative bacteria.
Tsubery H; Ofek I; Cohen S; Fridkin M
J Med Chem; 2000 Aug; 43(16):3085-92. PubMed ID: 10956216
[TBL] [Abstract][Full Text] [Related]
11. Development of dilipid polymyxins: Investigation on the effect of hydrophobicity through its fatty acyl component.
Domalaon R; Berry L; Tays Q; Zhanel GG; Schweizer F
Bioorg Chem; 2018 Oct; 80():639-648. PubMed ID: 30053708
[TBL] [Abstract][Full Text] [Related]
12. Direct modifications of the cyclic peptide Polymyxin B leading to analogues with enhanced in vitro antibacterial activity.
Brown P; Abdulle O; Boakes S; Duperchy E; Moss S; Simonovic M; Stanway S; Wilson A; Dawson MJ
Bioorg Med Chem Lett; 2020 Jun; 30(11):127163. PubMed ID: 32273214
[TBL] [Abstract][Full Text] [Related]
13. Interaction of W-substituted analogs of cyclo-RRRWFW with bacterial lipopolysaccharides: the role of the aromatic cluster in antimicrobial activity.
Bagheri M; Keller S; Dathe M
Antimicrob Agents Chemother; 2011 Feb; 55(2):788-97. PubMed ID: 21098244
[TBL] [Abstract][Full Text] [Related]
14. Probing the role of Proline in the antimicrobial activity and lipopolysaccharide binding of indolicidin.
Bera S; Ghosh A; Sharma S; Debnath T; Giri B; Bhunia A
J Colloid Interface Sci; 2015 Aug; 452():148-159. PubMed ID: 25935286
[TBL] [Abstract][Full Text] [Related]
15. Polymyxin B octapeptide and polymyxin B heptapeptide are potent outer membrane permeability-increasing agents.
Kimura Y; Matsunaga H; Vaara M
J Antibiot (Tokyo); 1992 May; 45(5):742-9. PubMed ID: 1624376
[TBL] [Abstract][Full Text] [Related]
16. Decreased binding of antibiotics to lipopolysaccharides from polymyxin-resistant strains of Escherichia coli and Salmonella typhimurium.
Peterson AA; Fesik SW; McGroarty EJ
Antimicrob Agents Chemother; 1987 Feb; 31(2):230-7. PubMed ID: 3032093
[TBL] [Abstract][Full Text] [Related]
17. Binding interactions of bacterial lipopolysaccharides to polymyxin B in an amphiphilic carrier 'sodium deoxycholate sulfate'.
Madhumanchi S; Suedee R; Nakpheng T; Tinpun K; Temboot P; Srichana T
Colloids Surf B Biointerfaces; 2019 Oct; 182():110374. PubMed ID: 31330430
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, and Bioactivity of Cyclic Lipopeptide Antibiotics with Varied Polarity, Hydrophobicity, and Positive Charge Distribution.
Cui AL; Hu XX; Chen Y; Jin J; Yi H; Wang XK; He QY; You XF; Li ZR
ACS Infect Dis; 2020 Jul; 6(7):1796-1806. PubMed ID: 32330004
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of a polymyxin derivative for photolabeling studies in the gram-negative bacterium Escherichia coli.
van der Meijden B; Robinson JA
J Pept Sci; 2015 Mar; 21(3):231-5. PubMed ID: 25640745
[TBL] [Abstract][Full Text] [Related]
20. Conformation of polymyxin B analogs in DMSO from NMR spectra and molecular modeling.
Liao SY; Ong GT; Wang KT; Wu SH
Biochim Biophys Acta; 1995 Oct; 1252(2):312-20. PubMed ID: 7578239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
